A protein particle hidden within the SARS-CoV-2 virus could lead to longer-lasting, more protective vaccines for COVID-19. Scientists from La Trobe University and Kumamoto University in Japan have ...
In a recent study published in the journal Nature Biotechnology, researchers engineered prime editor (PE)-engineered virus-like particles (eVLPs) delivering PE proteins, PE guide ribonucleic acids ...
MIT researchers have delivered a type of vaccine called a particulate vaccine to mice using a virus-mimicking scaffold made from particles of DNA instead of the usual protein particles. It not only ...
The Ebola virus (EBOV) matrix protein VP40 drives budding of virions and encodes 2 overlapping late domain motifs at amino acid positions 7–13 (PTAPPEY). However, these motifs are not absolutely ...
In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing rapid-onset memory loss and cognitive deficits. What triggers this sudden biological ...
A clinical-grade recombinant virus-like particle (VLP) vaccine has been developed to prevent human parvovirus B19 (HPVB19) infection, which can have severe and potentially fatal complications in ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...
The press release below was prepared by University of Utah Health. View the original. In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results